HLA-E, F, G interactions & the immunology of pregnancy
HLA-E、F、G 相互作用
基本信息
- 批准号:7410014
- 负责人:
- 金额:$ 36.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllogenicAntigensBindingBiochemistryBiologyCell surfaceCellsCharacteristicsChildClassComplexDeciduaDepthDevelopmentDoctor of PhilosophyEnvironmentHLA G antigenHistocompatibility Antigens Class IImmuneImmune responseImmune systemImmunologyInformation ResourcesInvadedLifeLigand BindingLigandsMediatingMembraneMothersNormal CellPeptidesPeripheralPlacentaPlayPregnancyPropertyReactionReagentRoleSignal TransductionStructureTestingTimeTissuesVascular blood supplyWorkcell typecytotrophoblastimplantationinterestpregnancy immunologyreceptortrophoblast
项目摘要
DESCRIPTION (provided by applicant): Pregnancy is arguably one of the most interesting examples of immune accommodation seen in mammalian biology. The placenta provides a barrier between the mother and child, regulating the reaction of maternal immune cells towards the allogeneic child at a time when its own immune system is immature or absent. Extravillous trophoblast (EVT) cells of the placenta invade deep into the maternal uterine tissue to establish a life giving connection with the maternal blood supply. It has been hypothesized that the interaction between EVT cells and maternal immune cells provides a controlling influence for implantation and development. We have been studying the biochemistry and immunology of the HLA-E, F, G class I molecules with a special focus on how they act individually and interactively, to help accommodate the maternal immune response to her developing offspring. We have recently shown that all placental cells that express HLA-G also express HLA-E and a subset of these also express HLA-F. Indeed, EVT cells that have invaded the maternal decidua are thus far the only normal cells known to simultaneously express all three nonclassical antigens. We propose to focus on features of HLA-E, F, and G that relate ultimately to their functions in the maternal-placental immune environment. Our current hypotheses concerning HLA-E, F, G in modifying a maternal immune response are being addressed in the following specific aims: 1) To examine the function of HLA-F in the peripheral immune response where we will decipher peptide or other ligand binding properties of HLA-F and identify a specific receptor interacting with HLA-F. This work is ultimately aimed at deciphering a specific role for HLA-F in the placental environment. 2) To test the ability of HLA-E bound to different peptide ligands, including the HLA-G nonamer, to evoke a specific immune response through binding an activatory receptor on maternal immune cells. This work will test the hypothesis that the HLA-G nonamer peptide bound to HLA-E confers a unique function on the complex necessary and specific for the placental immune environment. 3) To study soluble and membrane HLA-G with a major focus on determining their structural characteristics and interactions with inhibitory receptors. This work is aimed at testing the hypothesis that the primary function of HLA-G is to provide nonamer peptide to HLA-E and to otherwise act directly as a surrogate to classical class I interacting with inhibitory receptors expressed on decidual immune cells. We also propose to develop materials and reagents useful towards the further understanding of the structure, biochemistry, and function of HLA- E, F, and G.
描述(由申请人提供):可以说,怀孕是哺乳动物生物学中最有趣的免疫住宿的例子之一。胎盘在母亲和儿童之间提供障碍,在其自身免疫系统不成熟或不存在时调节母体免疫细胞对同种异体儿童的反应。胎盘的跨滋养细胞(EVT)细胞入侵了母体子宫组织,以建立与母体血液供应联系的生命。已经假设EVT细胞与母体免疫细胞之间的相互作用为植入和发育提供了控制影响。我们一直在研究HLA-E,F,G类分子的生物化学和免疫学,特别关注它们单独和互动的作用,以帮助适应其对她发展后代的产妇免疫反应。我们最近表明,所有表达HLA-G的胎盘细胞也表达HLA-E,其中一部分也表达HLA-F。实际上,侵入母体Decidua的EVT细胞是迄今为止唯一已知同时表达所有三种非经典抗原的正常细胞。我们建议专注于HLA-E,F和G的特征,该特征最终与它们在孕产妇免疫环境中的功能有关。在以下特定目的中解决了有关修饰母体免疫反应的HLA-E,F,G的当前假设:1)检查HLA-F在外围免疫反应中的功能,在其中我们将解解HLA-F的DETIPHE肽或其他配体结合特性,并确定特定的受体与HLA-F相互作用。最终,这项工作旨在破译HLA-F在胎盘环境中的特定作用。 2)测试HLA-E与不同肽配体(包括HLA-GNAMER)结合的能力,通过在母体免疫细胞上结合激活受体来唤起特定的免疫反应。这项工作将检验以下假设:与HLA-E结合的HLA-G非剂量肽在胎盘免疫环境所必需的和特定的复合物上赋予了独特的功能。 3)研究可溶性和膜HLA-G的主要重点是确定其结构特征和与抑制受体的相互作用。这项工作旨在检验以下假设:HLA-G的主要功能是为HLA-E提供非鉴定肽,并直接用作与在dec骨免疫细胞上表达的抑制受体相互作用的经典I类替代物。我们还建议开发材料和试剂,以进一步了解Hla-e,F和G的结构,生物化学和功能。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors.
- DOI:10.4049/jimmunol.1300081
- 发表时间:2013-10-01
- 期刊:
- 影响因子:0
- 作者:Goodridge JP;Burian A;Lee N;Geraghty DE
- 通讯作者:Geraghty DE
HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.
- DOI:10.1371/journal.pone.0163297
- 发表时间:2016
- 期刊:
- 影响因子:3.7
- 作者:Burian A;Wang KL;Finton KA;Lee N;Ishitani A;Strong RK;Geraghty DE
- 通讯作者:Geraghty DE
HLA-F complex without peptide binds to MHC class I protein in the open conformer form.
- DOI:10.4049/jimmunol.1000078
- 发表时间:2010-06-01
- 期刊:
- 影响因子:0
- 作者:Goodridge JP;Burian A;Lee N;Geraghty DE
- 通讯作者:Geraghty DE
HLA-F is a surface marker on activated lymphocytes.
- DOI:10.1002/eji.201040348
- 发表时间:2010-08
- 期刊:
- 影响因子:5.4
- 作者:Lee, Ni;Ishitani, Akiko;Geraghty, Daniel E.
- 通讯作者:Geraghty, Daniel E.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL E. GERAGHTY其他文献
DANIEL E. GERAGHTY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL E. GERAGHTY', 18)}}的其他基金
Characterizing Immunogenetics in Type 1 Diabetes
1 型糖尿病的免疫遗传学特征
- 批准号:
10585273 - 财政年份:2023
- 资助金额:
$ 36.17万 - 项目类别:
COVID-19 Supplemental work: NON-HUMAN PRIMATE MAJOR HISTOCOMPATIBILITY COMPLEX ALLELE DISCOVERY AND TYPING TECHNOLOGY DEVELOPMENT.
COVID-19 补充工作:非人类灵长类主要组织相容性复合体等位基因发现和分型技术开发。
- 批准号:
10260042 - 财政年份:2020
- 资助金额:
$ 36.17万 - 项目类别:
Complete genomic DNA sequence of the sooty mangabey MHC
乌白眉猴 MHC 的完整基因组 DNA 序列
- 批准号:
8018373 - 财政年份:2011
- 资助金额:
$ 36.17万 - 项目类别:
Complete genomic DNA sequence of the sooty mangabey MHC
乌白眉猴 MHC 的完整基因组 DNA 序列
- 批准号:
8238286 - 财政年份:2011
- 资助金额:
$ 36.17万 - 项目类别:
NHP Major Histocompatibility Complex Gene Discovery and Typing Technology
NHP主要组织相容性复合体基因发现和分型技术
- 批准号:
8335592 - 财政年份:2011
- 资助金额:
$ 36.17万 - 项目类别:
Diabetes and recombination in the 8.1 MHC haplotype
8.1 MHC 单倍型中的糖尿病和重组
- 批准号:
7224529 - 财政年份:2006
- 资助金额:
$ 36.17万 - 项目类别:
Diabetes and recombination in the 8.1 MHC haplotype
8.1 MHC 单倍型中的糖尿病和重组
- 批准号:
7295799 - 财政年份:2006
- 资助金额:
$ 36.17万 - 项目类别:
KIR Haplotype Sequencing A Comprehensive Picture of the Genetics of the KIR Locus
KIR 单倍型测序 KIR 基因座遗传学的全面图景
- 批准号:
6983617 - 财政年份:2005
- 资助金额:
$ 36.17万 - 项目类别:
HLA-E, F, G interactions & the immunology of pregnancy
HLA-E、F、G 相互作用
- 批准号:
6718594 - 财政年份:2004
- 资助金额:
$ 36.17万 - 项目类别:
HLA-E, F, G interactions & the immunology of pregnancy
HLA-E、F、G 相互作用
- 批准号:
7216387 - 财政年份:2004
- 资助金额:
$ 36.17万 - 项目类别:
相似国自然基金
肿瘤球混合堆砌-诱导分化构建同源性血管化结肠癌类器官用于血管发生干预靶点筛选
- 批准号:82373453
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
非小细胞肺癌中靶向抑制同源性重组修复增敏免疫检查点抑制剂疗效的研究和机制探索
- 批准号:82103045
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
非小细胞肺癌中靶向抑制同源性重组修复增敏免疫检查点抑制剂疗效的研究和机制探索
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FHF2对肥厚心肌钙致钙释放的影响及其机制研究
- 批准号:81900249
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
PTEN通过激活细胞程序性坏死通路促进APP淀粉样蛋白代谢的机制研究
- 批准号:81901116
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 36.17万 - 项目类别:
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies
基于同种异体 BAFF 配体的 CAR T 细胞作为 B 细胞恶性肿瘤的新疗法
- 批准号:
10698759 - 财政年份:2023
- 资助金额:
$ 36.17万 - 项目类别:
ADEPT-STAR therapy for high risk neuroblastoma
ADEPT-STAR 治疗高危神经母细胞瘤
- 批准号:
10760738 - 财政年份:2023
- 资助金额:
$ 36.17万 - 项目类别:
Prognostic implications of mitochondrial inheritance in myelodysplastic syndromes after stem-cell transplantation
干细胞移植后骨髓增生异常综合征线粒体遗传的预后意义
- 批准号:
10662946 - 财政年份:2023
- 资助金额:
$ 36.17万 - 项目类别:
Strategies to attenuate the indirect alloimmune response in encapsulated pancreatic islet transplantation
减弱封装胰岛移植中间接同种免疫反应的策略
- 批准号:
10678425 - 财政年份:2023
- 资助金额:
$ 36.17万 - 项目类别: